Prolidase activity in women with polycystic ovarian syndrome undergoing assisted conception

References

• Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. 2011. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting 2011. Human Reproduction, 26,1–6.
   Google Scholar
• Ambekar, A.S., et al., 2013. Proteomic analysis of human follicular fluid: a new perspective towards understanding folliculogenesis. Journal of Proteomics, 87, 68–77.
   PubMed Web of Science ®Google Scholar
• Awonuga, A.O., Camp, O.G. and Abu-Soud, H.M., 2023. A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS. Reproductive Biology and Endocrinology, 21 (1), 111.
   PubMed Web of Science ®Google Scholar
• Bahçeci, E., et al., 2021. Serum X-box-binding protein 1 levels in PCOS patients. Gynecological Endocrinology, 37 (10), 920–924.
   PubMed Web of Science ®Google Scholar
• Chakraborty, P., et al., 2013. Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome. Biological Trace Element Research, 152 (1), 9–15.
   PubMed Web of Science ®Google Scholar
• Da Broi, M.G., et al., 2018. Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications. Journal of Assisted Reproduction and Genetics, 35 (5), 735–751.
   PubMed Web of Science ®Google Scholar
• Eni-Aganga, I., et al., 2021. PROLIDASE: a review from discovery to its role in health and disease. Frontiers in Molecular Biosciences, 8 (31), 723003.
   PubMedGoogle Scholar
• Ergin Tuncay, M., et al., 2022. Modified proline metabolism and prolidase enzyme in COVID-19. Laboratory Medicine, 53 (5), 453–458.
   PubMed Web of Science ®Google Scholar
• Fedorcsák, P., et al., 2010. Differential release of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human granulosa-lutein cells and ovarian leukocytes. Endocrinology, 151 (3), 1290–1298.
   PubMed Web of Science ®Google Scholar
• Guney, G., et al., 2021. Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study. Therapeutic Advances in Endocrinology and Metabolism, 12, 20420188211049607.
   Web of Science ®Google Scholar
• Hilali, N., et al., 2013. Increased prolidase activity and oxidative stress in PCOS. Clinical Endocrinology, 79 (1), 105–110.
   PubMed Web of Science ®Google Scholar
• Hoeger, K.M., Dokras, A. and Piltonen, T., 2021. Update on PCOS: consequences, challenges, and guiding treatment. Journal of Clinical Endocrinology and Metabolism., 106 (3), 1071–1083.
   PubMed Web of Science ®Google Scholar
• Lambalk, C.B., et al., 2017. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Human Reproduction Update, 23 (5), 560–579.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2021. Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality. Journal of Assisted Reproduction and Genetics, 38 (2), 471–477.
   PubMed Web of Science ®Google Scholar
• Myara, I., et al., 1984. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clinical Chemistry, 30 (2), 211–215.
   PubMed Web of Science ®Google Scholar
• Nagyová, E., Němcová, L. and Camaioni, A., 2021. Cumulus extracellular matrix ıs an ımportant part of oocyte microenvironment in ovarian follicles: ıts remodeling and proteolytic degradation. International Journal of Molecular Sciences., 23 (1), 1–14.
   PubMed Web of Science ®Google Scholar
• Rehman, K.S., et al., 2007. Late stages of embryo progression are a much better predictor of clinical pregnancy than early cleavage in intracytoplasmic sperm injection and in vitro fertilization cycles with blastocyst-stage transfer. Fertility and Sterility, 87 (5), 1041–1052.
   PubMed Web of Science ®Google Scholar
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). 2004. Human Reproduction, 19, 41–47.
   Google Scholar
• Rudnicka, E., et al., 2021. Chronic low grade ınflammation in pathogenesis of PCOS. International Journal of Molecular Sciences., 22 (7), 1–12.
   Web of Science ®Google Scholar
• Syabakhash Raghdaa, A., Estabraq, A. and Enas, A., 2020. Actıvıty of prolıdase enzyme and ıts assocıatıon wıth number of antral follıcle count and obesıty ın polycystıc ovary syndrome. Biochemical & Cellular Archives, 20 (1), 1611–1617.
   Google Scholar
• Wilk, P., Wątor, E. and Weiss, M.S., 2021. Prolidase – a protein with many faces. Biochimie, 183, 3–12.
   PubMed Web of Science ®Google Scholar
• Zehravi, M., Maqboo, M. and Ara, I., 2021. Polycystic ovary syndrome and infertility: an update. International Journal of Adolescent Medicine and Health, 34 (2), 1–9.
   PubMedGoogle Scholar